JP2017501978A5 - - Google Patents

Download PDF

Info

Publication number
JP2017501978A5
JP2017501978A5 JP2016533153A JP2016533153A JP2017501978A5 JP 2017501978 A5 JP2017501978 A5 JP 2017501978A5 JP 2016533153 A JP2016533153 A JP 2016533153A JP 2016533153 A JP2016533153 A JP 2016533153A JP 2017501978 A5 JP2017501978 A5 JP 2017501978A5
Authority
JP
Japan
Prior art keywords
amino
alkyl
optionally substituted
methyl
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016533153A
Other languages
English (en)
Japanese (ja)
Other versions
JP6496728B2 (ja
JP2017501978A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/066608 external-priority patent/WO2015077451A1/en
Publication of JP2017501978A publication Critical patent/JP2017501978A/ja
Publication of JP2017501978A5 publication Critical patent/JP2017501978A5/ja
Application granted granted Critical
Publication of JP6496728B2 publication Critical patent/JP6496728B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016533153A 2013-11-21 2014-11-20 ホルミルペプチド受容体の調節因子としてのカルバミン酸フェニル誘導体 Expired - Fee Related JP6496728B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361907320P 2013-11-21 2013-11-21
US61/907,320 2013-11-21
PCT/US2014/066608 WO2015077451A1 (en) 2013-11-21 2014-11-20 Phenylcarbamate derivatives as formyl peptide receptor modulators

Publications (3)

Publication Number Publication Date
JP2017501978A JP2017501978A (ja) 2017-01-19
JP2017501978A5 true JP2017501978A5 (https=) 2017-11-24
JP6496728B2 JP6496728B2 (ja) 2019-04-03

Family

ID=52101595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016533153A Expired - Fee Related JP6496728B2 (ja) 2013-11-21 2014-11-20 ホルミルペプチド受容体の調節因子としてのカルバミン酸フェニル誘導体

Country Status (10)

Country Link
US (1) US9926264B2 (https=)
EP (1) EP3071548B1 (https=)
JP (1) JP6496728B2 (https=)
KR (1) KR102310615B1 (https=)
CN (1) CN105705484B (https=)
AU (1) AU2014352922B2 (https=)
BR (1) BR112016011417A8 (https=)
CA (1) CA2930084A1 (https=)
RU (1) RU2703725C1 (https=)
WO (1) WO2015077451A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106518742B (zh) 2011-10-26 2020-01-21 阿勒根公司 作为甲酰肽受体样-1(fprl-1)受体调节剂的n-脲取代的氨基酸的酰胺衍生物
BR112015021392B1 (pt) 2013-03-06 2021-11-16 Allergan, Inc Uso de agonistas do receptor de peptídeo formil 2 para tratar doenças dermatológicas
US9663457B2 (en) 2014-04-09 2017-05-30 Allergan, Inc. Carbamoyl hydrazine derivatives as formyl peptide modulators
CA2948876A1 (en) 2014-05-21 2015-11-26 Allergan, Inc. Imidazole derivatives as formyl peptide receptor modulators
GB201712282D0 (en) * 2017-07-31 2017-09-13 Nodthera Ltd Selective inhibitors of NLRP3 inflammasome

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05163221A (ja) * 1991-12-17 1993-06-29 Fujirebio Inc オキシ酸誘導体
US6495522B1 (en) * 1999-08-27 2002-12-17 Cytovia, Inc. Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
CN100506802C (zh) * 2004-06-04 2009-07-01 中国科学院上海药物研究所 一类甲酰肽样受体-1调节剂、其制备方法和用途
AU2010250789B2 (en) * 2009-05-18 2015-05-14 Actelion Pharmaceuticals Ltd Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
WO2012074785A1 (en) 2010-12-03 2012-06-07 Allergan, Inc. Pharmaceutical compositions comprising 3,4- dihydroisoquinolin-2(1 h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
AU2012214265A1 (en) 2011-02-11 2013-09-05 Allergan, Inc. Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
CN106518742B (zh) 2011-10-26 2020-01-21 阿勒根公司 作为甲酰肽受体样-1(fprl-1)受体调节剂的n-脲取代的氨基酸的酰胺衍生物
US8492556B2 (en) 2011-11-10 2013-07-23 Allergan, Inc. 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
US8541577B2 (en) 2011-11-10 2013-09-24 Allergan, Inc. Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators
CA2864893A1 (en) 2012-02-16 2013-08-22 Allergan, Inc. Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators
SG11201406629VA (en) 2012-04-16 2014-11-27 Allergan Inc (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
WO2015009545A1 (en) 2013-07-16 2015-01-22 Allergan, Inc. Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators
WO2015116574A1 (en) 2014-01-29 2015-08-06 Allergan, Inc. Urea hydantoin derivatives as formyl peptide modulators
WO2015116566A1 (en) 2014-01-29 2015-08-06 Allergan, Inc. 2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators
US9663457B2 (en) 2014-04-09 2017-05-30 Allergan, Inc. Carbamoyl hydrazine derivatives as formyl peptide modulators
CA2948876A1 (en) 2014-05-21 2015-11-26 Allergan, Inc. Imidazole derivatives as formyl peptide receptor modulators

Similar Documents

Publication Publication Date Title
JP2017501978A5 (https=)
RU2017129434A (ru) Амидные производные n-карбамид-замещенных аминокислот как модуляторы формилпептидного рецептора-1 (fprl-1)
JP2016529235A5 (https=)
JP2015520130A5 (https=)
JP2024543975A5 (https=)
RU2016119347A (ru) Производные фенилкарбамата в качестве модуляторов формилпептидного рецептора
ES2232114T3 (es) Derivados de cicloalqueno, procedimiento para su produccion, y uso.
JP2014525426A5 (https=)
NZ610230A (en) Compositions and methods for treating ocular edema, neovascularization and related diseases
JP2014525427A5 (https=)
RU2013132650A (ru) Серные производные в качестве модуляторов хемокиновых рецепторов
RU2013150332A (ru) Замещенные бициклические метиламинные производные как модуляторы рецепторов сфингозин-1-фосфата
NZ603198A (en) Novel hydroxamic acid derivative
JP2009542815A5 (https=)
JP2016512193A5 (https=)
EA201591775A1 (ru) Замещенные ароматические соединения и связанный с ними способ лечения фиброза
JP2015526487A5 (https=)
RU2009136911A (ru) Соединения, представляющие собой стиролильные производные, для лечения офтальмических заболеваний и расстройств
JP2014533274A5 (https=)
JP2015520130A (ja) ホルミルペプチド受容体2調節物質としての(2−ウレイドアセトアミド)アルキル誘導体
JP2012526082A5 (https=)
JP2017520528A5 (https=)
JP2017537937A5 (https=)
JP2018532692A (ja) ホルミルペプチド受容体1(fpr1)選択的アゴニストとしてのフェニル尿素類似体
RU2005137155A (ru) Производные 9-азабицикло [3.3.1] нон-6-ена с гетероатомом на позиции 3 как ингибиторы ренина